
    
      This is a prospective trial. Thirty-one patients with a primary pterygium of at least 2 mm in
      size and without any previous ocular surgery will be included. Outcome measures will include
      best corrected visual acuity, intraocular pressure, recurrence, and any sight threatening
      complications at two weeks, two months, and six months postoperatively.
    
  